Literature DB >> 10067894

Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2.

Y Yokota1, A Mansouri, S Mori, S Sugawara, S Adachi, S Nishikawa, P Gruss.   

Abstract

Transcription factors with a basic helix-loop-helix (HLH) motif have been shown to be crucial for various cell differentiation processes during development of multicellular organisms. Id proteins inhibit the functions of these transcription factors in a dominant-negative manner by suppressing their heterodimerization partners through the HLH domains. Members of the Id family also promote cell proliferation, implying a role in the control of cell differentiation. Here we show that Id2 is indispensable for normal development of mice. Id2-/- mice lack lymph nodes and Peyer's patches. However, their splenic architecture is normal, exhibiting T-cell and B-cell compartments and distinct germinal centres. The cell population that produces lymphotoxins, essential factors for the development of secondary lymphoid organs, is barely detectable in the Id2-/- intestine. Furthermore, the null mutants show a greatly reduced population of natural killer (NK) cells, which is due to an intrinsic defect in NK-cell precursors. Our results indicate that Id2 has an essential role in the generation of peripheral lymphoid organs and NK cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10067894     DOI: 10.1038/17812

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  320 in total

Review 1.  Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms.

Authors:  M E Massari; C Murre
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

2.  Evidence that helix-loop-helix proteins collaborate with retinoblastoma tumor suppressor protein to regulate cortical neurogenesis.

Authors:  J G Toma; H El-Bizri; F Barnabe-Heider; R Aloyz; F D Miller
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

3.  Lactation defect in mice lacking the helix-loop-helix inhibitor Id2.

Authors:  S Mori; S I Nishikawa; Y Yokota
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

Review 4.  A genetic investigation of E2A function in lymphocyte development.

Authors:  J Hanrahan; L Pan; S Greenbaum; C Bradney; M Hjelmeland; M Dai; Y Zhuang
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

5.  The MyoD-inducible p204 protein overcomes the inhibition of myoblast differentiation by Id proteins.

Authors:  Chuan-ju Liu; Bo Ding; Hong Wang; Peter Lengyel
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

6.  MyoD-dependent induction during myoblast differentiation of p204, a protein also inducible by interferon.

Authors:  C j Liu; H Wang; Z Zhao; S Yu; Y B Lu; J Meyer; G Chatterjee; S Deschamps; B A Roe; P Lengyel
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

7.  Loss of Id2 potentiates the tumorigenic effect of Rb inactivation in a mouse model of retinoblastoma.

Authors:  Solange Landreville; Duanduan Ma; Jun Wu; J William Harbour
Journal:  Curr Eye Res       Date:  2010-05       Impact factor: 2.424

8.  The E-Id Protein Axis Specifies Adaptive Lymphoid Cell Identity and Suppresses Thymic Innate Lymphoid Cell Development.

Authors:  Masaki Miyazaki; Kazuko Miyazaki; Kenian Chen; Yi Jin; Jacob Turner; Amanda J Moore; Rintaro Saito; Kenichi Yoshida; Seishi Ogawa; Hans-Reimer Rodewald; Yin C Lin; Hiroshi Kawamoto; Cornelis Murre
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

9.  Lineage relationships of human interleukin-22-producing CD56+ RORγt+ innate lymphoid cells and conventional natural killer cells.

Authors:  Yong-Oon Ahn; Bruce R Blazar; Jeffrey S Miller; Michael R Verneris
Journal:  Blood       Date:  2013-01-17       Impact factor: 22.113

10.  Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas.

Authors:  Michael D Onken; Justis P Ehlers; Lori A Worley; Jun Makita; Yoshifumi Yokota; J William Harbour
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.